Park's Pectus System
Tdm Co., Ltd. · Decision date Oct 15, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for Park's Pectus System, submitted by Tdm Co., Ltd. of Gwangju, Korea, under 510(k) number K263269. The decision date is 15 October 2026 and the application was received 18 September 2026. The device is listed under classification product code HRS, regulation number 888.3030, device classification name Plate, Fixation, Bone, with Orthopedic medical specialty and Orthopedic review panel. The submission is recorded as type Special, not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan.
SESE denotes 510(k) clearance, not premarket approval. The source records do not describe the device's components, materials, dimensions, indications for use, or the predicate device relied upon, and no summary statement content is available here. The specific clinical role of this fixation plate system therefore remains unknown from these records.
Industry readers should treat the clearance as a regulatory status record only; no safety, performance, or comparative effectiveness conclusions follow from it, and any labeling or indication details require the underlying FDA documents.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 15, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263269
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Tdm Co., Ltd.
- Product code
- HRS
- Decision code
- SESE
- Decision date
- Oct 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Plate, Fixation, Bone.
- Applicant
- Tdm Co., Ltd.
- Product code
- HRS
- FDA device class
- 2
FDA decision timeline
K263269 received
Application receipt date recorded by FDA.
K263269 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HRS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
HERO Sternal Closure SystemK262939 | Hero Orthopedics, LLC | 510(k) clearance | Nov 2, 2026 | FDA |
| ARTHREX, INC. | 510(k) clearance | Oct 29, 2026 | FDA | |
| Skeletal Dynamics, Inc. | 510(k) clearance | Oct 26, 2026 | FDA | |
ANTHEM Fracture SystemK262779 | GLOBUS MEDICAL, INC. | 510(k) clearance | Oct 23, 2026 | FDA |
Tempo Plating SystemK263407 | Pace Surgical | 510(k) clearance | Oct 23, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Tdm Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Gwangju
Sources and methodology
- Original FDA record: K263269
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


